Literature DB >> 23542734

Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection.

Edgar Bautista1, Magali Arcos, Luís Jimenez-Alvarez, Ma Cecilia García-Sancho, María E Vázquez, Erika Peña, Anjarath Higuera, Gustavo Ramírez, Rosario Fernández-Plata, Alfredo Cruz-Lagunas, Sara A García-Moreno, Francisco Urrea, Remedios Ramírez, Ricardo Correa-Rotter, José Rogelio Pérez-Padilla, Joaquín Zúñiga.   

Abstract

Acute kidney injury (AKI) is often associated to acute respiratory distress syndrome (ARDS) due to influenza A/H1N1 virus infection. The profile of angiogenic and inflammatory factors in ARDS patients may be relevant for AKI. We analyzed the serum levels of several angiogenic factors, cytokines, and chemokines in 32 patients with A/H1N1 virus infection (17 with ARDS/AKI and 15 ARDS patients who did not developed AKI) and in 18 healthy controls. Significantly higher levels of VEGF, MCP-1, IL-6, IL-8 and IP-10 in ARDS/AKI patients were detected. Adjusting by confusing variables, levels of MCP-1 ≥150 pg/mL (OR=12.0, p=0.04) and VEGF ≥225 pg/mL (OR=6.4, p=0.03) were associated with the development of AKI in ARDS patients. Higher levels of MCP-1 and IP-10 were significantly associated with a higher risk of death in patients with ARDS (hazard ratio (HR)=10.0, p=0.02; HR=25.5, p=0.03, respectively) even taking into account AKI. Patients with influenza A/H1N1 infection and ARDS/AKI have an over-production of MCP-1, VEGF and IP-10 possibly contributing to kidney injury and are associated to a higher risk of death.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542734     DOI: 10.1016/j.yexmp.2013.03.007

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  17 in total

1.  Bronchoalveolar fluid and plasma inflammatory biomarkers in contemporary ARDS patients.

Authors:  Renee D Stapleton; Benjamin T Suratt; Margaret J Neff; Mark M Wurfel; Lorraine B Ware; John T Ruzinski; Ellen Caldwell; Teal S Hallstrand; Polly E Parsons
Journal:  Biomarkers       Date:  2019-03-04       Impact factor: 2.658

2.  TGF-β Blood Levels Distinguish Between Influenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired Pneumonia.

Authors:  Erick J Rendón-Ramirez; Alejandro Ortiz-Stern; Corazon Martinez-Mejia; Mario C Salinas-Carmona; Adrian Rendon; Viviana L Mata-Tijerina; Adrian G Rosas-Taraco
Journal:  Viral Immunol       Date:  2015-04-29       Impact factor: 2.257

3.  Effect of Repeated Recruitment Manoeuvres on Patients with Severe Acute Respiratory Distress Syndrome.

Authors:  M-Q Li; G-J Han; J-Q Li; J-Y Xu; Z-X Shi; Z Zhang; F Lu; X-M Wang; Y-J Xu; X Mo
Journal:  West Indian Med J       Date:  2015-05-15       Impact factor: 0.171

4.  Plasma Monocyte Chemotactic Protein-1 Is Associated With Acute Kidney Injury and Death After Cardiac Operations.

Authors:  Dennis G Moledina; Selin Isguven; Eric McArthur; Heather Thiessen-Philbrook; Amit X Garg; Michael Shlipak; Richard Whitlock; Peter A Kavsak; Steven G Coca; Chirag R Parikh
Journal:  Ann Thorac Surg       Date:  2017-02-21       Impact factor: 4.330

5.  Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.

Authors:  Jiajia Wang; Xinjing Yang; Yongsheng Li; Jian-An Huang; Junhong Jiang; Nan Su
Journal:  Virol J       Date:  2021-06-04       Impact factor: 4.099

6.  Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).

Authors:  José Alberto Choreño-Parra; Luis Armando Jiménez-Álvarez; Alfredo Cruz-Lagunas; Tatiana Sofía Rodríguez-Reyna; Gustavo Ramírez-Martínez; Montserrat Sandoval-Vega; Diana Lizzeth Hernández-García; Eduardo M Choreño-Parra; Yalbi I Balderas-Martínez; Mariana Esther Martinez-Sánchez; Eduardo Márquez-García; Edda Sciutto; José Moreno-Rodríguez; José Omar Barreto-Rodríguez; Hazel Vázquez-Rojas; Gustavo Iván Centeno-Sáenz; Néstor Alvarado-Peña; Citlaltepetl Salinas-Lara; Carlos Sánchez-Garibay; David Galeana-Cadena; Gabriela Hernández; Criselda Mendoza-Milla; Andrea Domínguez; Julio Granados; Lula Mena-Hernández; Luis Ángel Pérez-Buenfil; Guillermo Domínguez-Cheritt; Carlos Cabello-Gutiérrez; Cesar Luna-Rivero; Jorge Salas-Hernández; Patricio Santillán-Doherty; Justino Regalado; Angélica Hernández-Martínez; Lorena Orozco; Federico Ávila-Moreno; Ethel A García-Latorre; Carmen M Hernández-Cárdenas; Shabaana A Khader; Albert Zlotnik; Joaquín Zúñiga
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

Review 7.  Biomarkers in critical illness: have we made progress?

Authors:  Patrick M Honore; Rita Jacobs; Inne Hendrickx; Elisabeth De Waele; Viola Van Gorp; Olivier Joannes-Boyau; Jouke De Regt; Willem Boer; Herbert D Spapen
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-10-17

8.  CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats.

Authors:  Shan Lang; Libing Li; Xuning Wang; Junping Sun; Xinying Xue; Yongjiu Xiao; Mingyue Zhang; Ting Ao; Jianxin Wang
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

9.  Mathematical modeling of postcoinfection with influenza A virus and Streptococcus pneumoniae, with implications for pneumonia and COPD-risk assessment.

Authors:  Yi-Hsien Cheng; Shu-Han You; Yi-Jun Lin; Szu-Chieh Chen; Wei-Yu Chen; Wei-Chun Chou; Nan-Hung Hsieh; Chung-Min Liao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-05

10.  Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients.

Authors:  Cassianne Robinson-Cohen; Ronit Katz; Brenda L Price; Susanna Harju-Baker; Carmen Mikacenic; Jonathan Himmelfarb; W Conrad Liles; Mark M Wurfel
Journal:  Crit Care       Date:  2016-07-03       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.